ArticleOncoTargets and therapy2020

MRPL13 is a Prognostic Cancer Biomarker and Correlates with Immune Infiltrates in Breast Cancer.

Zuo Tao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.